And on the fourth day?
Printable View
There speaks a short-term trader. You're absolutely right to sell. This is a share for those who understand what A2 is all about.
On the money there NT001, I'm in for long haul...have seen the sp swing between 46c (small paper loss) all the way to 80c (big paper profit) in the last few months or so. No inclination whatsoever to sell, if anything might top up more on further weakness or participate in capital raising, if there is going to be one.
Wow that was a busy day, sold 91,000 and bought 10,000 and a $14,000 profit:D.
I'm struggling to find anything negative in the numbers. Its a better result than what I was expecting.
Sure they have made a loss are going to need to do a CR but a2mc is not and never has been a company that over exaggerates its forecasts, in fact traditionally they have been fairly conservative. Accept that the cash flow from ANZ operations is not going to cut it, however they may use some of their credit lines currently in place to fund the difference. That may only require $10 to $15m and at say 7%pa close to half the total cost of what was required to list on the ASX.
The positive thing is why wouldn't they build on the initial success they are getting in the USA. Forecasts of revenue from $1.9 FY15 to $38m needs funding. I'm suspecting that $38m is a bit conservative as well.
Then its baby formula. Already they have $13m of revenue in 2 months, so annualized that's $78m a 87.18% increase over FY15. Suspect that's conservative as well.
Then there is growing revenue coming in through product diversification and more health studies on human subjects that are also looking positive.
Happy to see a2mc go for it and happy to add to my holdings.